Today, UCB issued the following statement jointly from Camille Lee, Head of U.S. Immunology, and Jeff Stark, M.D., Head of U.S. Medical Immunology, on the recent update by the ICD-10 Coordination and Maintenance Committee (a subcommittee of the U.S. Centers for Disease Control and Prevention) to endorse and make public that non-radiographic axial spondyloarthritis (nr-axSpA) will be formally indexed to ICD-10 sub category M46.8; these changes will be effective for diagnoses starting October 1, 2020 and more information is available on the Centers for Medicare & Medicaid Service (CMS) website which outlines the specific coding changes in greater detail:

At UCB, patients are at the heart of everything we do. Read more from Brad Chapman, U.S. Head of Internal Operations and West Ecosystem - Neurology, on how our agile ways of working are helping us keep our commitment to patients, physicians, and the communities we serve in a work-from-home world.

Despite the unprecedented events stemming from the novel coronavirus, we are pleased to continue our mission of investing in the next generation of the work force by welcoming 18 student interns to our first virtual internship program.

At UCB, we know we’re stronger when we work together. Read more from Patty Fritz, VP of U.S. Corporate Affairs, about how UCB adapted in response to the COVID-19 pandemic to met the new unique needs of the patients, caregivers, health care providers, and health systems we’re committed to serving.

For MG Awareness Month, we're spreading awareness about myasthenia gravis (MG) by showcasing Jennifer's inspiring story about living with the disease. Hear about her experience and advice for others living with MG by watching the video below.

Although this June may look and feel different from years past, we’re just as excited to spread awareness together with the myasthenia gravis (MG) community in celebration of Myasthenia Gravis (MG) Awareness Month. In light of the impact coronavirus is having on people around the world, especially people with MG who may be immunocompromised, we’re looking forward to connecting and celebrating in a virtual way.

UCB has been making ongoing adjustments to ensure continuous care for patients, including people living with immune-mediated inflammatory diseases during this time of great isolation. Hear more from UCB's Head of U.S. Immunology, Camille Lee, about our efforts to better support patients during this time.

At UCB, everything we do starts with one simple question: “How will this make a difference in the lives of people living with severe diseases?” This question is our motivation, inspiration and what challenges us to stay focused on what will ultimately benefit the patients we serve. Read more from Camille Lee, Head of U.S. Immunology, about how UCB is working to empower patients impacted by immuno-dermatological conditions.

Congratulations to Andrea Loewendorf – Head, Market Access and Innovation Strategy, Neurology and Jessica Williamson, PhD – Protein Production Lead for their recognition as a Healthcare Businesswomen's Association (HBA) Rising Stars for 2020!

At UCB, we are using our passion and expertise to address gaps in post-fracture care to provide patients the support they need. This Osteoporosis Awareness Month, read from Alison Kocanda, Head of U.S. Bone, as she shares how UCB is supporting patients through education and resources.